How the Supreme Court’s new gun and drug ruling relates to Iran (or doesn’t)

Welcome back, Deadline: Legal Newsletter readers. I’m writing to you a day early this week, ahead of the Juneteenth holiday on Friday.  

Fresh off the Trump administration’s Iranian agreement, let’s go back to early March, right after the U.S. and Israel struck the Middle Eastern nation. That’s when the Supreme Court heard argument in United States v. Hemani. Technically, Iran had nothing to do with the legal issue in the case, which was whether the Second Amendment barred the prosecution of Ali Danial Hemani under a federal law disarming anyone who is “an unlawful user of or addicted to any controlled substance.”

But the administration highlighted an Iranian connection in pressing the justices to take up Hemani’s case. In its petition, the Justice Department said that the dual U.S.-Pakistani citizen had “drawn the attention” of the FBI, and that he was “poised to commit fraud at the direction of suspected affiliates of the Iranian Revolutionary Guard Corps” and had “traveled to Iran to participate in a celebration of the life of Qasem Soleimani, an Iranian general and terrorist who had been killed by an American drone strike.”

What did any of that have to do with the Second Amendment? Gun rights advocates had the same question. They warned the justices not to fall for what they saw as an underhanded litigation tactic of the government: “handpicking unsympathetic criminal defendants to justify its preferred gun control.” Groups led by Gun Owners of America said the court should “decide the easy question presented and ignore the Government’s irrelevant character assassination.”

The court did just that on Thursday, when all nine justices sided with Hemani. “The charge had nothing to do with terrorism,” Justice Neil Gorsuch observed in his opinion.

Leave a Comment